Ann Arbor, MI, United States of America

Ly Pham

This inventor holds 1 USPTO granted patent. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ly Pham. Retrieved from https://idiyas.com/inventor/ly-pham-p67129ha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ly Pham

Introduction

Ly Pham is an accomplished inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that can modulate chemokine receptor function. Her work is crucial in addressing inflammatory diseases and viral infections.

Latest Patents

Ly Pham holds a patent for "Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor." This patent discloses novel compounds that can be used to modulate chemokine receptor function, including methods for treating patients with inflammatory diseases and viral infections, specifically targeting those infected with HIV. She has 1 patent to her name.

Career Highlights

Ly Pham is currently associated with Millennium Pharmaceuticals Limited, where she continues to innovate and contribute to the pharmaceutical industry. Her expertise in the modulation of chemokine receptors has positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Ly has collaborated with notable colleagues, including Yuntao Song and Bharat Kalidas Trivedi. These collaborations have further enhanced her research and development efforts.

Conclusion

Ly Pham's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions to the modulation of chemokine receptors are paving the way for new treatments for serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…